Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31209707 | 0.88 | EPHX1 (0.39) | USP2SMN1; SMN2EPHX1NR1H2HPGD | |
| SCHEMBL31209512 | 0.88 | EPHX1 (0.39) | USP2SMN1; SMN2EPHX1NR1H2HPGD | |
| SCHEMBL31209428 | 0.79 | EPHX2 (0.38) | USP2SMN1; SMN2EPHX1NR1H2HPGD | |
| SCHEMBL30738959 | 0.77 | USP2 (0.43) | USP2SMN1; SMN2RECQLNR1H2ALDH1A1 | |
| SCHEMBL31209365 | 0.76 | USP2 (0.42) | USP2SMN1; SMN2RECQLEPHX1NR1H2 | |
| SCHEMBL17107692 | 0.74 | EPHX1 (0.39) | USP2SMN1; SMN2RECQLEPHX1NR1H2 | |
| SCHEMBL3178498 | 0.73 | EPHX1 (0.41) | USP2SMN1; SMN2EPHX1NR1H2HPGD | |
| SCHEMBL3186800 | 0.72 | EPHX1 (0.43) | USP2SMN1; SMN2EPHX1NR1H2HPGD | |
| SCHEMBL3190015 | 0.72 | EPHX1 (0.40) | EPHX1NR1H2HPGDEPHX2ALDH1A1 | |
| SCHEMBL29589441 | 0.71 | EHMT2 (0.44) | USP2SMN1; SMN2RECQLEPHX1NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368193-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY | 2024-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368193-A1 | KRAS INHIBITORS | KRAS, NRAS, HRAS | USP2 3256/4885SMN1; SMN2 4044/4885RECQL 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.